Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
The current Johnson & Johnson(JNJ) stock price is $267.63, with a market capitalization of 645.01B. The stock trades at a price-to-earnings (P/E) ratio of 31.52 and offers a dividend yield of 1.94%.
During the trading session on 2026-09-29, Johnson & Johnson(JNJ) shares reached a daily high of $272.02 and a low of $265.59. At a current price of $267.63, the stock is +0.8% higher than the low and still -1.6% under the high.
Trading volume for Johnson & Johnson(JNJ) stock has reached 5.62M, versus its average volume of 6.76M.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $281.07 and a low of $179.80.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $281.07 and a low of $179.80.
JNJ News
Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) closed at $267.66 in the latest trading session, marking a -1.58% move from the prior day. The stock'...
When seeking reliable dividend payouts, look no further than the Dividend Kings. Several members of the elite club, including Johnson & Johnson (JNJ Quick Quote...
...
Analyst ratings
70%
of 27 ratingsMore JNJ News
Johnson & Johnson (NYSE:JNJ) is scheduled to report its third-quarter fiscal 2027 results on Nov. 12. Bank of America Securities analyst Jason Gerberry expects...
(RTTNews) - Tuesday, Johnson & Johnson (JNJ) said new data from the Phase 2/3 long-term extension study showed sustained disease control through two years, alon...
Johnson & Johnson announced new findings on Imaavy – nipocalimab-aahu – for the treatment of generalized myasthenia gravis, or gMG, across 15 novel abstracts to...
Investing Living Off Dividends at 65: 3 Stocks That Raised Payouts for Longer Than 30 Years Three stocks have raised their dividends for over 30 consecutive yea...
JPMorgan raised the firm’s price target on Johnson & Johnson to $285 from $270 and keeps a Neutral rating on the shares ahead of the earnings report on October...
Johnson & Johnson's oncology and immunology pipeline is firing on multiple cylinders, but a collapsing blockbuster drug and mounting litigation costs threaten t...
Johnson & Johnson reported past clinical milestones for TREMFYA in axial psoriatic arthritis and long-term CARTITUDE-2 data for CARVYKTI in early line multiple...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.